Characterizing the genomic and immunologic landscape of serous borderline tumors and low-grade serous ovarian cancer

被引：0
|
作者：
Krishnan, Rahul
Bilecz, Agnes
Herbst, Paula
Shimizu, Aasa
Schweizer, Lisa
Jaeger, Ellen
Godden, Jen
Stoppler, Melissa
Yamada, Diane
Lengyel, Ernst
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 05期
关键词：
D O I：
10.1158/1538-7445.OVARIAN23-A107
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A107
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The Genomic Landscape of Low-Grade Serous Ovarian/Peritoneal Carcinoma (LGSOC) and its Impact on Clinical Outcome
    Gershenson, David
    Sun, Charlotte
    Westin, Shannon
    Eyada, Mostafa
    Cobb, Lauren
    Nathan, Lisa
    Sood, Anil
    Malpica, Anais
    Hillman, Robert
    Wong, Kwong
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 166 : S52 - S52
  • [42] SELUMETINIB HAS ACTIVITY IN LOW-GRADE SEROUS OVARIAN CANCER
    不详
    [J]. CANCER DISCOVERY, 2013, 3 (02) : 134 - 134
  • [43] Characterizing FOLR1 expression in low-grade serous ovarian carcinoma
    Rushton, Tullia
    Krause, Harris Benjamin
    Elliott, Andrew
    Karnezis, Anthony
    Toboni, Michael Driscoll
    Thaker, Premal H.
    Braxton, David R.
    Oberley, Matthew James
    Gershenson, David Marc
    Armstrong, Deborah Kay
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] CD 56 expression in serous invasive ovarian cancer and serous ovarian borderline tumors
    Pokieser, W.
    Hauptmann, S.
    [J]. VIRCHOWS ARCHIV, 2010, 457 (02) : 151 - 151
  • [45] Genomic imbalances in ovarian borderline serous and mucinous tumors.
    Khanna, V
    Hu, J
    Jones, MW
    Surti, U
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 234 - 234
  • [46] Borderline With Bad Behavior: An Unusual Low-grade Serous Carcinoma With Dedifferentiation From a Serous Borderline Tumor
    Strickland, Amanda L.
    Maniar, Kruti P.
    Tanner, Edward
    Shanes, Elisheva
    Jennings, Lawrence
    Wei, Jian-Jun
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2023, 42 (03) : 241 - 246
  • [47] PLZF Immunostaining Distinguishes Low-Grade and High-Grade Ovarian Serous Tumors
    Liu, Y.
    Kinoshita, Y.
    Kalir, T. L.
    Burstein, D. E.
    [J]. MODERN PATHOLOGY, 2011, 24 : 257A - 257A
  • [48] BORDERLINE AND LOW-GRADE SEROUS OVARIAN CARCINOMA: ANALYSIS OF THE CLINICAL BEHAVIOR IN 151 PATIENTS
    Rotsaert, A.
    Moerman, P.
    Leunen, K.
    Amant, F.
    Neven, P.
    Vergote, I.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [49] The continuum of serous tumors of low malignant potential and low-grade serous carcinomas of the ovary
    Wong, Kwong-Kwok
    Gershenson, David
    [J]. DISEASE MARKERS, 2007, 23 (5-6) : 377 - 387
  • [50] Management challenges in low-grade serous ovarian cancer with a BRCA mutation
    Sanchez-Lorenzo, Luisa
    Sancho, Lidia
    Iscar, Teresa
    Grisham, Rachel
    Chiva, Luis
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (04) : 631 - 636
12345